Clinical Trial Update: Pazopanib in Treating Patients With Metastatic Urothelial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of pazopanib in metastatic urothelial cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urethral Cancer
• Urothelial Cancer
• Urothelial Carcinoma of the Renal Pelvis
• Urothelial Carcinoma of the Ureter

Drugs mentioned

• Votrient (Pazopanib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Distal Urethral Cancer, Proximal Urethral Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-03-21